Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves
marketwatch.com/story/biogen-first-quarter-profit-tops-estimates-as-alzheimers-drug-uptake-improves-ece3714f
Biogen shares gained ground before market open Wednesday, after the company reported first-quarter profit that beat analysts’ expectations amid improving uptake of its Alzheimer’s treatment.
This story appeared on marketwatch.com, 2024-04-24.